top of page

Hereditary Cancer Panel

Original price

£599.99

Sale price

£499.99

Hereditary Cancer Panel — Comprehensive Genetic Risk Screening

The Hereditary Cancer Panel is a clinically curated genetic test designed to identify inherited gene variants associated with an increased risk of developing certain cancers. By analysing multiple cancer-related genes in a single test, it provides valuable insight into your inherited cancer susceptibility and supports proactive, informed health decisions.

This test is particularly suitable for individuals with a personal or family history suggestive of hereditary cancer risk.

Hereditary Cancer Panels

Shipment

Biomarkers checked

Comprehensive Hereditary Cancer Panel APC, ATM1, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK22, EPCAM3, HOXB13, MLH1, MSH2, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS24, POLD1, POLE, PTEN, RAD51C, RAD51D, SMAD4, STK11, TP53, VHL
Hereditary Breast Cancer Panel ATM1, BARD1, BRCA1, BRCA2, CHEK22, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53
Hereditary Breast and Gynaecological Cancer Panel ATM1, BARD1, BRCA1, BRCA2, BRIP1, CHEK22, EPCAM3, MLH1, MSH2, MSH6, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53
Hereditary Prostate Cancer ATM1, BRCA1, BRCA2, CHEK22, EPCAM3, HOXB13, MLH1, MSH2, MSH6
Hereditary Colorectal Cancer (including Lynch syndrome) Panel APC, BMPR1A, EPCAM3, MLH1, MSH2, MSH6, MUTYH, NTHL1, PMS24, POLD1, POLE, PTEN, SMAD4, STK11, TP53
Hereditary Melanoma Cancer Panel BAP1, BRCA2, CDK4, CDKN2A, PTEN
Hereditary Pancreatic Cancer Panel APC, BRCA1, BRCA2, CDKN2A EPCAM3, MLH1, MSH2, MSH6, PALB2, STK11, TP53, VHL

 

 

 

Key Features

  • Comprehensive multi-gene analysis of hereditary cancer risk markers

  • Assesses genes associated with breast, ovarian, colorectal, prostate, pancreatic, melanoma and other inherited cancers

  • Designed for individuals with a personal or family history of cancer

  • Professional clinical interpretation included

  • Genetic counselling support available where clinically indicated

  • Clear, actionable results to guide screening and prevention strategies

Collection Method

  • Saliva sample collection — simple, non-invasive and completed at home

  • No blood draw or clinical appointment required

  • Sample stabilised for safe transport to the laboratory

  • Prepaid return packaging included

The process is discreet, convenient, and easy to complete following the step-by-step instructions provided.

Report Contents

Your comprehensive clinical report includes:

  • Identification of detected genetic variants

  • Clinical classification and interpretation of results

  • Explanation of associated cancer risks (where relevant)

  • Personalised recommendations for screening or medical follow-up

  • Guidance on next steps and risk-management options

Results are provided securely after laboratory analysis.

Scientific Technology

The Hereditary Cancer Panel uses validated Next-Generation Sequencing (NGS) technology to analyse multiple cancer-associated genes simultaneously.

Advanced bioinformatics pipelines and expert clinical review are used to detect and classify genetic variants in accordance with recognised clinical interpretation guidelines. This ensures high analytical accuracy and meaningful, clinically relevant reporting.

What’s Included

  • Saliva collection kit with detailed instructions

  • Sample stabilisation tube

  • Prepaid return packaging

  • Accredited laboratory analysis

  • Comprehensive clinical report

  • Access to genetic counselling support (where appropriate)

Accuracy

The Hereditary Cancer Panel delivers high analytical sensitivity and specificity through rigorous sequencing quality control, validation processes, and expert variant interpretation.

A positive result indicates an increased inherited cancer risk but does not confirm the presence of cancer. A negative result does not eliminate all cancer risk, as not all genetic factors may be currently detectable or understood.

This test is intended to support informed clinical decision-making in consultation with a healthcare professional.

Accreditation

Testing is performed in laboratories operating under a quality management system accredited to:

  • UKAS ISO 15189:2012 (Medical Laboratories – Quality and Competence)

ISO 15189 accreditation confirms that the laboratory meets internationally recognised standards for clinical testing quality, technical competence, and reliability.

All laboratory processes follow strict quality assurance protocols, including validated sequencing methods, controlled sample handling, and secure, confidential data reporting

bottom of page